Only 5 Short Weeks Left Until Investment In Innovation (In3) Europe, April 29-30 in Paris, France, Presented by Medtech Insight and Windhover Conferences

IRVINE, Calif.--(Business Wire)--
In just 5 short weeks, Medtech Insight and Windhover Conferences will host
"Investment In Innovation (In3) Europe," a very special international medical
technology investment and partnering event, being held at the Marriott Rive
Gauche Hotel & Conference Center in Paris, France. We invite you and your
colleagues to join us April 29th and 30th, and take advantage of our $100
registration savings offer, before March 27th only! (Additional multiple
registration discounts also offered.)

The 2-day In3 Europe event - proudly, our 35th In3 conference - will showcase
over 30 highly promising, innovative, early-to-late-stage medical device
companies from around the world presenting (many for the first time on our
stage) to an audience of senior business development and investment executives
from the leading medical technology and healthcare investment firms worldwide,
for purposes of raising funding or forming strategic partnerships.

Company presentations will consist of a carefully selected group of
cutting-edge, start-up companies encompassing a wide variety of high-growth
device sectors, including cardiovascular therapeutics and
diagnostics/interventional cardiology, diagnostics, drug delivery, imaging,
minimally invasive surgery, nanotechnology, neurostimulation, oncology,
ophthalmic technology, orthopedics/spine, peripheral vascular, stem cells,
stroke management, tissue engineering, and wound management, to mention only a
few.

Please make plans to join us in Paris this April forInvestment In Innovation
(In3) Europe, bridging European and U.S. Medical Device Innovators, Investors
and Companies.

REGISTER BY FRIDAY, MARCH 27, 2009 AND SAVE $100! Plus receive a FREE GIFT with
Your Registration: 3 month subscription to ANYMedtech Insight or Windhover
Information Publication (InVivo, Start Up, or The Gray Sheet) of your choice,
with your PAID Registration.

(Note: additional discounts available when registering multiple attendees and
only applicable to new paid attendees.)

Event info: www.windhover.com/in3europe09.

Presenting Companies Confirmed to Date (30+ at time of event)

* Bioactive Bone Substitutes Ltd. Oy (First-Time Presenter) Yliopisto, Finland -
Specializing in innovative therapeutic substances for bone regeneration.
* Cardio³ Biosciences SA - Braine L'Alleud, Belgium - A leading edge company,
founded in 2007 and active in the field of regenerative therapies for the
treatment of heart failure.
* Cardiola, Ltd. - Winterthur, Switzerland - Non-invasive Chronic Heart Failure
treatment device using Muscular Counter Pulsation (MCP). The20m.pulse device is
poised for at home treatment, has received CE clearance and the company is
currently ramping up sales and marketing activities.
* Invendo Medical GmbH - Kissing, Germany - Developed the only next-generation
disposable colonoscope incorporating diagnostic and therapeutic capabilities
allowing for a potentially sedation-less treatment.
* Lifenova Biomedical SA (First-Time Presenter) San Sebastian, Spain -
Clinically proved surface technology improving the osseointegration of load
bearing, e.g. dental, implants.
* Medical Device Works (First-Time Presenter) Brussells, Belgium - The only set
of catheters for percutaneous isolation of an organ (liver) and local delivery
of (any) high dosage chemotherapy for treatment of organ cancer.
* mNemoscience - Aachen, Germany - Biocompatible shape memory polymers (BIO-SMP)
which can be programmed to change shapes and rigidity when an initiating
stimulus, such as e.g. change in temperature, is applied.
* MTM Laboratories - Westborough, MA - Biomarkers for the screening and
diagnosis of cancers; initial focus is on Cervical Cancer.
* Nanobiotix - Paris, France - New treatments for cancer based on the combined
application of nanotechnologies and biotechnologies.
* NOLabs AB (First-Time Presenter) Helsingborg, Sweden - A medical device
company that intends to become the world leader in diabetes neuropathy related
pain control.
* Photo Dynamic Therapy - Vienna, Austria - Clinical hands-on service with
non-invasive tumor treatment modality specific to patients` individual need by
intelligent laser light and photon transformer.
* PolyMedix, Inc. - Radnor, PA - Novel anti-microbial polymeric coatings for
devices and implants.
* Quanta Fluid Solutions (First-Time Presenter) Warwickshire, United Kingdom -
Introducing SelfCare+, a cartridge based portable Haemodialysis Machine designed
for patient use at home. Delivers world class clinical performance but only the
size of a carry-on suitcase.
* Sensile Medical AG (First-Time Presenter) Hägendorf, Switzerland -
Nanoliter-based devices for continuous glucose monitoring and micro insulin
delivery systems.
* Sensimed AG - Lausanne, Switzerland - Soft disposable contact lens embedding
MEMS and telemetry monitoring intraocular pressure continuously and
non-invasively.
* Symetis SA - Lausanne, Switzerland - 2nd generation trans-apical aortic valve
replacement system. In-vivo validation on-going. First-in-man Q3/09.
* ThermopeutiX, Inc. - San Diego, CA - Catheter-based systems that will provide
very rapid and selective hypothermia to various body organs and locations.
* Vittamed (First-Time Presenter) Kaunas, Lithuania - Developed breakthrough
non-invasive medical device technology for the monitoring of absolute value of
intracranial pressure, cerebral blood flow autoregulation and intracranial
volumetric waves in patients with traumatic brain injuries and spinal injuries
or other intracraniospinal pathologies.
* Vivostat A/B - Alleroed, Denmark - Vivostat A/S manufactures and sells a
surgical sealant and a gel to treat chronic wounds. Both are based on the
individual patient's own blood. A third product can be used as a drug delivery
media for topical use.

VC Panel - Wednesday, April 29th
Panel Discussion: Trends in European Dealmaking and Investing (details)

Deal Maker Panel - Thursday, April 30th (details)
State of the Medical Device Industry Address by Medtech Insight/Windhover's Device Editorial Team

Panel Discussion - Thursday, April 30th (details)
Best Practices and Lessons from the Front Lines: CEOs Talk about Building Successful Companies in Europe Today

Sponsors

AdvaMed, Life Science Intelligence, MDMA, MTB Europe, Ron Trahan & Associates,
The Gray Sheet, Medtech Insight/Windhover Information, FDC Reports, and Reed
Elsevier among others to be announced.

REGISTER before March 27, 2009 and receive $100 off single registration with
additional discounts available when registering multiple attendees, plus receive
a free gift of Metech Insight, InVivo, Start Up, or The Gray Sheet, of your
choice, with your paid subscription. To inquire or to register simply call one
of the number listed below.

Medtech Insight, Windhover, FDC Reports
an Elsevier Company
Kristy J. Grimes
Associate Sales Director Medical Devices
Tel 480-985-9512
Fax 480-218-4027
kristy@medtechinsight.com
kgrimes@windhover.com
k.grimes@elsevier.com
www.medtechinsight.com
or
Kayleen Kell
Account Executive
Tel 949-453-0071 ext.313
or 888-290-2225 toll-free in the U.S.
k.kell@elsevier.com

Copyright Business Wire 2009